Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.14 Insider Own24.34% Shs Outstand20.94M Perf Week0.00%
Market Cap92.95M Forward P/E- EPS next Y-0.82 Insider Trans0.00% Shs Float20.75M Perf Month1.19%
Income-27.41M PEG- EPS next Q-0.24 Inst Own23.83% Short Float / Ratio0.07% / 0.09 Perf Quarter132.19%
Sales0.96M P/S96.83 EPS this Y27.59% Inst Trans6.49% Short Interest0.01M Perf Half Y111.88%
Book/sh0.57 P/B5.98 EPS next Y21.90% ROA-85.62% Target Price3.12 Perf Year-16.50%
Cash/sh0.61 P/C5.51 EPS next 5Y- ROE-113.53% 52W Range0.91 - 4.35 Perf YTD13.38%
Dividend- P/FCF- EPS past 5Y- ROI-149.50% 52W High-22.07% Beta0.01
Dividend %- Quick Ratio3.46 Sales past 5Y891.07% Gross Margin-73.07% 52W Low273.97% ATR0.07
Employees76 Current Ratio3.46 Sales Q/Q-9.83% Oper. Margin-2985.57% RSI (14)77.21 Volatility1.38% 1.14%
OptionableYes Debt/Eq0.21 EPS Q/Q35.28% Profit Margin-2861.11% Rel Volume0.26 Prev Close3.35
ShortableYes LT Debt/Eq0.18 EarningsNov 14 AMC Payout- Avg Volume157.81K Price3.39
Recom2.00 SMA200.95% SMA5041.76% SMA20097.94% Volume41,462 Change1.19%
Nov-14-23 04:05PM
Nov-09-23 10:17AM
Nov-07-23 01:52PM
Nov-06-23 12:19AM
Oct-30-23 08:06AM
06:05AM Loading…
Oct-11-23 04:05PM
Oct-05-23 04:30PM
Sep-06-23 04:01PM
Sep-05-23 04:04PM
Aug-21-23 09:51AM
Aug-15-23 07:30AM
Aug-14-23 04:01PM
Jul-25-23 04:01PM
Jul-17-23 07:09AM
04:01PM Loading…
Jul-13-23 04:01PM
Jun-01-23 04:01PM
May-30-23 04:08PM
May-11-23 05:45PM
Apr-27-23 06:00PM
Apr-10-23 07:01AM
Apr-05-23 06:55AM
Apr-03-23 06:27AM
Mar-31-23 05:15PM
Mar-15-23 04:01PM
Mar-07-23 08:35PM
04:01PM Loading…
Mar-06-23 08:15AM
Feb-06-23 06:52AM
Feb-01-23 08:00AM
Dec-15-22 09:10AM
Dec-14-22 05:30PM
Nov-21-22 07:01AM
Nov-17-22 05:02AM
Nov-14-22 04:01PM
Nov-09-22 08:25AM
Nov-08-22 03:40PM
Nov-03-22 04:01PM
Oct-19-22 07:00AM
Oct-05-22 04:01PM
Sep-26-22 04:01PM
Sep-20-22 04:01PM
Sep-10-22 08:47AM
Aug-25-22 07:00AM
Aug-23-22 07:00AM
Aug-15-22 04:01PM
Aug-10-22 07:00AM
Aug-01-22 04:01PM
Jul-11-22 07:00AM
Jul-05-22 07:01AM
May-31-22 04:30PM
May-25-22 04:30PM
May-17-22 04:39PM
May-16-22 04:01PM
Apr-28-22 04:01PM
Apr-19-22 07:00AM
Mar-30-22 04:01PM
Mar-29-22 07:00AM
Mar-17-22 04:01PM
Mar-16-22 04:01PM
Mar-01-22 05:15PM
Feb-10-22 07:00AM
Feb-01-22 07:00AM
Jan-06-22 04:46PM
Jan-05-22 07:00AM
Dec-17-21 07:00AM
Nov-15-21 04:01PM
Oct-28-21 04:01PM
Oct-12-21 03:57PM
Oct-07-21 05:30AM
Sep-24-21 09:52AM
Sep-20-21 07:00AM
Sep-09-21 08:00AM
Aug-11-21 07:00AM
Jun-28-21 04:01PM
Jun-24-21 07:00AM
Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care. The company was founded in 2009 by Doris A. Taylor and Cohen Robert and is headquartered in Eden Prairie, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ERB JOHN LDirectorMar 10Buy1.6031,25050,00056,260Mar 30 04:57 PM
Heine Lisa WippermanDirectorMar 10Buy1.6031,25050,00080,155Mar 30 04:56 PM
Burke William P. Mr.DirectorMar 10Buy1.6031,25050,00080,155Mar 30 04:57 PM
Douglas James MichaelCHIEF FINANCIAL OFFICERMar 10Buy1.6031,25050,00051,250Mar 30 05:01 PM
Ross Jeffrey JamesCHIEF EXECUTIVE OFFICERMar 10Buy1.6031,25050,000396,276Mar 30 05:00 PM
Maag PeterDirectorMar 10Buy1.6031,25050,00066,259Mar 30 04:58 PM
BUCKMAN PAULDirectorMar 10Buy1.6031,25050,00052,593Mar 30 04:59 PM
Barry John JosephVICE PRESIDENT OF R&DMar 10Buy1.606,25010,00035,485Mar 30 04:59 PM